OpenVSafe by OpenVAERS
Search V-safe

7R7-10844-19929

5 vaccinations 12 coded responses 53 check-ins 10 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
563 / MN
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-30
    Registered in v-safe
  2. 2020-12-30
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-30
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  4. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Chills, Headache, Nausea · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-01-04
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  10. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  11. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  12. 2021-01-13
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  13. 2021-01-20
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-20
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  16. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Oedema peripheral, Tenderness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Axillary swelling, pain, tenderness on vaccinated side.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Axillary lymph node pain and swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Lymphadenopathy — Feeling: Good
    Free text: Axillary lymph node pain and swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good
    Free text: Mild axillary lymph node swelling/tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-01-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-04-21
    Survey response — 3 months, dose 2
    MedDRA: COVID-19, Essential hypertension — Feeling: Good · Be unable to work, Be unable to do your normal daily activities
    Free text: COVID-19, essential hypertension
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-07-24
    Survey response — 6 months, dose 2
    MedDRA: COVID-19, Dyspnoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Ongoing shortness of breath from COVID infection that began 3/15/2021
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  29. 2021-09-09
    Dose 3 — Pfizer-BioNTech
  30. 2021-09-29
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-05
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-12-09
    Survey response — 3 months, dose 3
    MedDRA: Breakthrough COVID-19, Dyspnoea, Hypertension — Feeling: Good · Be unable to do your normal daily activities
    Free text: Ongoing symptoms since breakthrough Covid infection 3/15/21. Dyspnea and hypertension.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-03-10
    Survey response — 6 months, dose 3
    MedDRA: Breast pain, Lymph node pain, Muscular weakness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Tender lymph nodes in vaccinated arm (left), left arm weakness associated with left breast pain.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-05-18
    Dose 4 — Pfizer-BioNTech
  35. 2022-05-19
    Survey response — days 1–6 daily, dose 4
    MedDRA: Musculoskeletal stiffness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Stiffness
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-05-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  37. 2022-05-21
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  38. 2022-05-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  39. 2022-05-23
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  40. 2022-05-24
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  41. 2022-05-27
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  42. 2022-06-01
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-06-14
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  44. 2022-06-15
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-06-22
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-07-01
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  47. 2022-08-17
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  48. 2022-11-16
    Survey response — 6 months, dose 4
    MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: On week 6 of an upper respiratory infection
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-12-07
    Dose 5 — Pfizer-BioNTech
  50. 2022-12-10
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Adult check-in
  51. 2022-12-11
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Redness, Itching · Headache, Fatigue or tiredness
    Adult check-in
  52. 2022-12-12
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness
    Adult check-in
  53. 2022-12-13
    Health check-in — days 1–6 daily, dose 5
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  54. 2022-12-16
    Health check-in — day 7, dose 5
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  55. 2022-12-21
    Health check-in — day 14, dose 5
    Feeling: Fair
    Adult check-in
  56. 2022-12-28
    Health check-in — day 21, dose 5
    Feeling: Fair
    Adult check-in
  57. 2023-01-04
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  58. 2023-01-18
    Health check-in — day 42, dose 5
    Feeling: Fair
    Adult check-in
  59. 2023-03-10
    Survey response — 3 months, dose 5
    MedDRA: Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  60. 2023-06-07
    Survey response — 6 months, dose 5
    MedDRA: Skin discolouration — Feeling: Fair
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Pfizer-BioNTech
22021-01-20Pfizer-BioNTech
32021-09-09Pfizer-BioNTech No
42022-05-18Pfizer-BioNTech No
52022-12-07Pfizer-BioNTech No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-22

Systemic reaction (other): Axillary swelling, pain, tenderness on vaccinated side.

2021-01-23

Systemic reaction (other): Axillary lymph node pain and swelling

2021-01-24

Systemic reaction (other): Axillary lymph node pain and swelling

2021-01-25

Systemic reaction (other): Mild axillary lymph node swelling/tenderness

Release 7 — 3 months, dose 2

2021-04-21

Symptoms: COVID-19, essential hypertension

Release 9 — 6 months, dose 2

2021-07-24

Symptoms: Ongoing shortness of breath from COVID infection that began 3/15/2021

Release 10 — 3 months, dose 3

2021-12-09

Symptoms: Ongoing symptoms since breakthrough Covid infection 3/15/21. Dyspnea and hypertension.

Release 11 — 6 months, dose 3

2022-03-10

Symptoms: Tender lymph nodes in vaccinated arm (left), left arm weakness associated with left breast pain.

Release 11 — days 1–6 daily, dose 4

2022-05-19

Systemic reaction (other): Stiffness

Release 12 — 6 months, dose 4

2022-11-16

Symptoms: On week 6 of an upper respiratory infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBreakthrough COVID-19 · · ✓
SDBreast pain · · ✓
SDCOVID-19 ✓ ✓ ✓
SDDyspnoea ✓ · ✓
SDEssential hypertension ✓ ✓ ✓
SDHypertension · · ✓
SDLymph node pain · · ✓
SDMuscular weakness · · ✓
SDSkin discolouration · · ✓
SDUpper respiratory tract infection · · ✓
SDViral infection · · ✓
SROAxillary pain ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROMusculoskeletal stiffness · · ✓
SROOedema peripheral ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release